Glycometabolism & Hypophyseal Hormone Test Kit for Chemiluminescence Immunoassay Analyzer C-P INS

^{C-peptide(C-P)}

^{(1) Determination of C-peptide concentration is helpful for the clinical classification of diabetes and helps to understand the islet function of patients.}

^{(2) Because C-peptide is not interfered by islet antibodies, the concentration of C-peptide can be directly measured in patients receiving insulin therapy to judge the patient's islet function.}

^{(3) The cause of hypoglycemia can be identified. If the C-peptide exceeds normal, it can be considered to be caused by excessive insulin secretion; if the C-peptide value is lower than normal, it is caused by other reasons.}

^{(4) The determination of C-peptide is helpful for the diagnosis of islet cell tumor and the judgment of the effect of insulinoma surgery. The level of C-peptide in the blood of insulinoma is high. If the level of C-peptide in the blood is still high after surgery, it means that there is residual tumor tissue. During follow-up, the level of C-peptide continued to rise, suggesting the possibility of tumor recurrence or metastasis.}

^{Insulin (INS)}

^{1. Determine whether a diabetic patient is a type 1 patient or a type 2 patient, and determine the function of β cells.}

^{2. Monitor serum insulin levels so that doctors can determine the correct treatment plan.}

^{3. It is mainly suitable for patients without insulin treatment. It can be measured by drawing blood on an empty stomach and 2 hours after a meal, and the postprandial level should be 4-5 times higher than that on an empty stomach. If the insulin level is significantly reduced, it is called an absolute deficiency, which can be seen in type 1 diabetes; if there is no significant reduction, but the blood sugar rises, it is called a relative deficiency, because there is a malfunction in the link where insulin works, which is often seen in Type 2 diabetes with insulin resistance.}